Allergy

Latest News

$While omalizumab remains the most validated biologic option for CSU unresponsive to antihistamines, the emergence of dupilumab and remibrutinib as effective alternatives signifies a shift in the management of refractory CSU. | Image Credit: StockWorld - stock.adobe.com$

Expanding Treatment Options for Chronic Spontaneous Urticaria

By Kimberly Rath, PharmD

September 5th 2025

The chronic spontaneous urticaria treatment landscape has shifted in recent years, with expanding treatment options for patients with refractory disease.

A pragmatic, food-based, low-dose OIT protocol was effective at inducing peanut desensitization after 12 months and was associated with meaningful quality of life improvement. | Image Credit: Angela Schmidt - stock.adobe.com

Peanut Allergy Treatment Improves Quality of Life vs Peanut Avoidance

By Jared Kaltwasser

August 28th 2025

While the findings are preliminary, clinicians may want to consider screening patients with chronic urticaria for metabolic syndrome as a part of their routine care. | Image credit: inthasone - stock.adobe.com

Patients With Chronic Urticaria May Face Higher Risk of Metabolic Syndrome

By Jared Kaltwasser

August 27th 2025

The results of the study show that synthetic data could maintain accuracy down to 25% of the original real-world data sample size. | Image credit: tippapatt - stock.adobe.com

Smaller Trials, Bigger Impact: The Potential of Synthetic Data in CSU

By Kimberly Rath, PharmD

August 22nd 2025

Chronic urticaria. | Image Credit: doucefleur - stock.adobe.com

Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?

By Cameron Santoro

August 15th 2025

More News

June 14th 2024

Newer Treatments for CSU Show Fast Response, Says Dr Gil Yosipovitch

Data on new treatments for chronic spontaneous urticaria (CSU) show significant symptom reduction very early during treatment.

June 7th 2024

Dr Gil Yosipovitch: Biologics Have Changed the World of CSU Care

Given the lack of efficacy of antihistamines for most patients with chronic spontaneous urticaria (CSU), biologics have changed the entire world of CSU.

May 24th 2024

Patients With CSU Need New Therapies, Says Dr Jonathan Bernstein

While there is treatment for chronic spontaneous urticaria (CSU), there remains a need for newer therapies, explained allergy specialist Jonathan Bernstein, MD.

May 17th 2024

CSU Can Affect All Aspects of Patients’ Lives, Explained Dr Jonathan Bernstein

The chronic nature of the hives affecting patients with chronic spontaneous urticaria (CSU) can really affect all aspects of their lives, including sleep, daily activities, work, and interpersonal relationships.

May 10th 2024

Chronic and Unpredictable: The Anxiety of Living With CSU

The chronic and unpredictable nature of chronic spontaneous urticaria (CSU) can cause crippling anxiety around how long the painful symptoms of the disease will last, explained Kristen Willard, a patient advocate with CSU.

May 3rd 2024

The Challenging Diagnosis and Long Treatment Journey of CSU, From a Patient Perspective

The pain of chronic spontaneous urticaria (CSU) can be crippling, explained Kristen Willard, a patient advocate with CSU, who discussed her treatment journey.

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions